Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Hospital Infection Control & Prevention



  • APIC Research Agenda Includes Race and HAIs

    With the SARS-CoV-2 pandemic exposing widespread inequities and deep-set systemic racism in healthcare, the Association for Professionals in Infection Control and Epidemiology is planning research to address some of these critical issues, including one proposal to design a study to determine if patients of color or non-white ethnicity are at greater risk of acquiring healthcare-associated infections.

  • Your Brain on COVID: Damage Found in Two New Studies

    Dementia and other adverse effects on the brain are occurring in some COVID-19 survivors, an ominous finding for the millions infected even those with only mild symptoms, according to two new studies.

  • Misinformation Continues to Undermine Pandemic Response

    Misinformation and outright lies have swept the globe during the last two years, undermining the pandemic response in hospitals and communities. In a recent call to action report, the Association for Professionals in Infection Control and Epidemiology warned infection preventionists this phenomenon has been harmful and no doubt will occur during the next pandemic.

  • APIC Asks Feds for Infection Prevention Reinforcements

    The leading organization for infection preventionists is trying to elevate and solidify their role in healthcare after many were dislodged from traditional duties or otherwise overwhelmed during the pandemic. The Association for Professionals in Infection Control and Epidemiology has issued a call to action report, which describes IPs as key players in pandemics and emergency response, as well as the longstanding wall between vulnerable patients and healthcare infections.

  • Mind the Gap: A Wary Shift from Pandemic to Endemic

    As COVID-19 cases drop dramatically and public health officials relax masking guidelines based on the local situation, there is the temptation to assume the pandemic is over and is entering a broadly defined endemic phase.

  • Urgent Need for ‘Universal’ Vaccines for SARS-CoV-2

    There is an emerging consensus in the scientific community that is two-fold: COVID-19 is not going away anytime soon, and continuous vaccine boosters eventually could yield diminishing returns. What is needed are new, second-generation vaccines that confer broader immunity against both circulating variants and mutations yet to arise.

  • APIC Sets New Strategic Priorities Amid COVID-19

    Like other healthcare workers, infection preventionists have been overwhelmed in the churning waves of the SARS-CoV-2 pandemic. An unpublished survey conducted by the Association for Professionals in Infection Control and Epidemiology and The Ohio State University School of Nursing revealed a “startling” level of stress and burnout.

  • Omicron ‘Milder’ Infection View Skewed by Prior Immunity

    The COVID-19 omicron variant has been widely observed to cause “milder” disease, but this appears largely to be an illusion caused by the level of immunity via prior infection or vaccination that now exists in the human population.

  • Infectious Disease Experts Sound Alarm on True Toll of RSV

    Respiratory syncytial virus (RSV) is something of a contradiction: The leading cause of hospitalization of infants in the United States (58,000 annually) is largely unappreciated beyond the pediatric population. In what essentially is a hidden seasonal epidemic, RSV causes 177,000 hospitalizations and 14,000 deaths annually in the United States in those age 65 years and older.

  • Vaccines Saved 1 Million Lives in 2021

    COVID-19 vaccines prevented an estimated 1 million deaths and 10 million hospitalizations in the United States in 2021, according to a new modeling study by the Commonwealth Fund.